title: The role of estrogen receptor-beta, in the early age-related bone gain and later age-related bone loss in female mice.
abstract: The molecular and cellular mechanism of estrogen action in skeletal tissue remains unclear. The purpose of this study was to understand the role of estrogen receptor-beta, (ERbeta) on cortical and cancellous bone during growth and aging by comparing the bone phenotype of 6- and 13-month-old female mice with or without ERbeta. Groups of 11-14 wild-type (WT) controls and ERbeta knockout (BERKO) female mice were necropsied at 6 and 13 months of age. At both ages, BERKO mice did not differ significantly from WT controls in uterine weight and uterine epithelial thickness, indicating that ERbeta does not regulate the growth of uterine tissue. Femoral length increased significantly by 5.5% at 6 months of age in BERKO mice compared with WT controls. At 6 months of age, peripheral quantitative computerized tomography (pQCT) analysis of the distal femoral metaphysis (DFM) and femoral shafts showed that BERKO mice had significantly higher cortical bone content and periosteal circumference as compared with WT controls at both sites. In contrast to the findings in cortical bone, at 6 months of age, there was no difference between BERKO and WT mice in trabecular density, trabecular bone volume (TBV), or formation and resorption indices at the DFM. In 13-month-old WT mice, TBV (-41%), trabecular density (-27%) and cortical thickness decreased significantly. while marrow cavity and endocortical circumference increased significantly compared with 6-month-old WT mice. These age-related decreases in cancellous and endocortical bone did not occur in BERKO mice. At 13 months of age, BERKO mice had significantly higher total, trabecular and cortical bone, while having significantly lower bone resorption, bone formation and bone turnover in DFM compared with WT mice. These results indicate that deleting ERbeta protected against age-related bone loss in both the cancellous and endocortical compartments by decreasing bone resorption and bone turnover in aged female mice. These data demonstrate that in female mice, ERbeta plays a role in inhibiting periosteal bone formation, longitudinal and radial bone growth during the growth period, while it plays a role in stimulating bone resorption, bone turnover and bone loss on cancellous and endocortical bone surfaces during the aging process.
authors.affiliation: Department of Cardiovascular Diseases, Groton Laboratories, Connecticut 06340, USA. huazhu_ke@groton.pfizer.com
authors.forename: H Z
authors.initials: HZ
authors.lastname: Ke
authors.forename: T A
authors.initials: TA
authors.lastname: Brown
authors.forename: H
authors.initials: H
authors.lastname: Qi
authors.forename: D T
authors.initials: DT
authors.lastname: Crawford
authors.forename: H A
authors.initials: HA
authors.lastname: Simmons
authors.forename: D N
authors.initials: DN
authors.lastname: Petersen
authors.forename: M R
authors.initials: MR
authors.lastname: Allen
authors.forename: J D
authors.initials: JD
authors.lastname: McNeish
authors.forename: D D
authors.initials: DD
authors.lastname: Thompson